Does ABOBOTULINUMTOXINA Cause Injection site swelling? 146 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Injection site swelling have been filed in association with ABOBOTULINUMTOXINA. This represents 2.5% of all adverse event reports for ABOBOTULINUMTOXINA.
146
Reports of Injection site swelling with ABOBOTULINUMTOXINA
2.5%
of all ABOBOTULINUMTOXINA reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site swelling From ABOBOTULINUMTOXINA?
Of the 146 reports, 5 (3.4%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABOBOTULINUMTOXINA. However, 146 reports have been filed with the FAERS database.
What Other Side Effects Does ABOBOTULINUMTOXINA Cause?
Off label use (2,271)
Drug ineffective (1,677)
Product preparation error (751)
Headache (379)
Overdose (344)
Inappropriate schedule of drug administration (318)
Therapeutic response shortened (313)
Eyelid ptosis (301)
Injection site pain (278)
Muscular weakness (272)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which ABOBOTULINUMTOXINA Alternatives Have Lower Injection site swelling Risk?
ABOBOTULINUMTOXINA vs ABRAXANE
ABOBOTULINUMTOXINA vs ABROCITINIB
ABOBOTULINUMTOXINA vs ACALABRUTINIB
ABOBOTULINUMTOXINA vs ACAMPROSATE
ABOBOTULINUMTOXINA vs ACARBOSE